Corline Biomedical isn't a profitable company, so it is unlikely we'll see a strong correlation between its share price and its earnings per share (EPS). Arguably revenue is our next best option.

Want to participate in a short research study? Help shape the future of investing tools and you could win a $250 gift card! Corline Biomedical AB (STO:CLBIO) shareholders might be concerned after ...

Corline Biomedical AB OverviewBiotechnology / Healthcare Corline Biomedical AB develops, manufactures, and markets heparin based solutions to enhance kidney transplantation, cell therapies, and ...

* CORLINE BIOMEDICAL AB HAS COMPLETED PATIENT RECRUITMENT IN THE ONGOING STUDY RENAPAIR-01, IN WHICH CO'S DRUG CANDIDATE RENAPARIN® IS EVALUATED FOR SAFETY IN ADMINISTRATION IN CONNECTION WITH KIDNEY ...

Add Yahoo as a preferred source to see more of our stories on Google. Not sure where to grab a bite to eat? With lots of options around the Taunton area, it can be difficult to choose. If you’re ...

The big shareholder groups in Corline Biomedical AB (STO:CLBIO) have power over the company. Large companies usually have institutions as shareholders, and we usually see insiders owning shares in ...

Stockholm, June 3, 2015 — Nasdaq (Nasdaq: NDAQ) announces that the trading in Corline Biomedical AB’s shares (short name: CLBIO) commenced today on Nasdaq First North in Stockholm. Corline belongs to ...

If you're interested in Corline Biomedical AB (STO:CLBIO), then you might want to consider its beta (a measure of share price volatility) in order to understand how the stock could impact your ...

Corline Biomedical AB (CLBIO) has delivered a 85.76% change over the past year, with a 52-week range between 8.20 and 27.20. What Is the Average Daily Trading Volume of Corline Biomedical AB (CLBIO)?

* About 23.5 million Swedish crowns ($2.90 million), equivalent to 92.2 pct, were subscribed for with subscription rights * About 2.0 million crowns, equivalent to 7.8 pct, were subscribed for without ...

As of 11:49:39 a.m. GMT+2. Market Open.

Corline Biomedical AB has a price-to-earnings (P/E) ratio of -31.66 (TTM). This compares to an industry average of 26.39. What is Corline Biomedical AB’s price-to-sales ratio? The P/S ratio for ...